| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenue | 9,855 | 3,140 | 3,489 | 3,558 |
| Cost of revenue (exclusive of depreciation and amortization, shown separately below) | 7,462 | 2,691 | 2,871 | 3,064 |
| Sales and marketing | 1,779 | 1,073 | 1,022 | 616 |
| General and administrative | 3,217 | 2,872 | 2,085 | 1,182 |
| Research and development | 85 | 278 | 59 | 55 |
| Bad debt expense | 125 | 77* | -20 | NaN |
| Depreciation and amortization | 810 | 590* | 63 | 0 |
| Total operating expenses | 6,016 | 4,890 | 3,209 | 1,853 |
| Loss from operations | -3,623 | -4,441 | -2,591 | -1,359 |
| Other income | 8 | 2 | 731 | 13 |
| Changes in fair value | 2,435 | -10* | NaN | NaN |
| Interest expense | -85 | -101 | -32 | -21 |
| Forex gain | -63 | 28* | -14 | NaN |
| Loss before income tax | -6,198 | -4,502 | -1,906 | -1,368 |
| Provision for income tax | NaN | NaN | NaN | 0 |
| Net loss | -6,198 | -4,502 | -1,906 | -1,368 |
| Foreign currency translation gain | -166 | 5 | 6 | NaN |
| Comprehensive loss | -6,364 | -4,497 | -1,900 | NaN |
| Basic EPS | -6.81 | -72.681 | -0.42 | -0.58 |
| Diluted EPS | -6.81 | -72.681 | -0.42 | -0.58 |
| Basic Average Shares | 930,672 | 61,873* | 4,443,784 | 2,343,385 |
| Diluted Average Shares | 930,672 | 61,873* | 4,443,784 | 2,343,385 |
Healthcare Triangle, Inc. (HCTI)
Healthcare Triangle, Inc. (HCTI)